ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock Earnings & Estimates
USA - NASDAQ:ARTV - US04317A1079 - Common Stock
3.49 USD
-0.4 (-10.28%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.931M 146.30% | 33.492M 579.21% | 251K -99.25% | -100.00% | 11.44M | 81.491M 612.33% | 181.18M 122.33% | 346.8M 91.41% | 528.8M 52.48% | |||
| EBITDA YoY % growth | -58.671M -10.65% | -28.405M 51.59% | -64.851M -128.31% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -59.829M -12.31% | -30.671M 48.74% | -67.282M -119.37% | -93.74M -39.32% | -100.544M -7.26% | -123.928M -23.26% | -88.84M 28.31% | -89.484M -0.72% | -49.634M 44.53% | 57.936M 216.73% | 159.22M 174.82% | |
| Operating Margin | -1,213.32% | -91.58% | -26,805.58% | N/A | N/A | N/A | -776.57% | -109.81% | -27.40% | 16.71% | 30.11% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.57 34.13% | -3.48 2.57% | -2.70 22.45% | -3.38 -25.17% | -3.06 9.37% | -1.12 63.33% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.83 -26.42% | -0.90 -8.88% | -0.86 0.81% | -0.85 3.33% | -0.78 6.11% | -0.79 12.87% | -0.70 19.39% | -0.71 16.43% | -0.74 5.99% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.538M -28.86% | -24.31M -9.65% | -25.67M -12.54% | -27.353M -14.64% | -24.82M -5.44% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.88 4.86% | -0.89 | 0.01 | 0.83% |
| Q2 2025 Q2Q % growth | -0.87 96.05% | -0.82 | -0.05 | -5.74% |
| Q1 2025 Q2Q % growth | -0.83 | -0.72 | -0.11 | -14.53% |
| Q4 2024 Q2Q % growth | -0.66 | -0.77 | 0.11 | 14.30% |
| Q3 2024 Q2Q % growth | -0.93 | -0.93 | 0.01 | 0.71% |
| Q2 2024 Q2Q % growth | -22.00 | -4.49 | -17.51 | -390.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | -100.00% | 59.497K | -59.497K | -100.00% |
| Q2 2024 Q2Q % growth | 76.5K | -76.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -0.58% | 0% | -6.49% |
| Revenue | N/A | N/A | N/A | N/A |